600
Participants
Start Date
October 20, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
July 30, 2026
ERAS group
This group will include patients that achieved a compliance rate that exceeded 80% of the required predetermined criteria of ERAS protocols.
Control group
This group will include patients that do not follow the predetermined criteria of ERAS protocols
RECRUITING
Agios Savvas Anticancer Hospital, Athens
RECRUITING
First department of Obstetrics and Gynecology, Athens
RECRUITING
First department of Obstetrics and Gynecology, National and Kapodistrian University of Athens, Athens
NOT_YET_RECRUITING
Metaxa Anticancer Hospital, Athens
RECRUITING
Aristotle University of Thessaloniki, Second department of Obstetrics and Gynecology, Thessaloniki
RECRUITING
Aristotle University of Thessaloniki, Third department of Obstetrics and Gynecology, Thessaloniki
RECRUITING
Aristotle University of Thesalloniki, Papageorgiou Hospiral, Thessaloniki
RECRUITING
University of Thessaly, Larissa
University of Thessaly
OTHER
Aristotle University Of Thessaloniki
OTHER
Metaxa Hospital
OTHER
Saint Savvas Anticancer Hospital
OTHER
National and Kapodistrian University of Athens
OTHER